53 phenotypes from 5 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Ncf1em1(IMPC)Mbp/Ncf1em1(IMPC)Mbp C57BL/6N-Ncf1em1(IMPC)Mbp/MbpMmucd	abnormal behavior	J:211773
	abnormal eye morphology	J:211773
	abnormal heart morphology	J:211773
	abnormal kidney morphology	J:211773
	abnormal lung morphology	J:211773
	abnormal lymph node morphology	J:211773
	abnormal skin morphology	J:211773
	abnormal spleen morphology	J:211773
	decreased anxiety-related response	J:211773
	decreased locomotor activity	J:211773
	decreased thigmotaxis	J:211773
	enlarged kidney	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased heart atrium size	J:211773
	single kidney	J:211773
	small kidney	J:211773
Ncf1em1Nansh/Ncf1em1Nansh involves: C57BL/6J	normal hematopoietic system phenotype	J:329553
	normal immune system phenotype	J:329553
	increased susceptibility to induced morbidity/mortality	J:329553
Ncf1m1J/Ncf1m1J B6.Cg-Dock7m +/+ Leprdb/J	abnormal macrophage physiology	J:83428
	decreased susceptibility to Orthomyxoviridae infection	J:145306
	impaired granulocyte bactericidal activity	J:83428
Ncf1m1J/Ncf1m1J involves: C57BL/6	oxidative stress	J:207291
Ncf1tm1Hbd/Ncf1tm1Hbd involves: 129	abnormal bile duct morphology	J:74593
	abnormal lung morphology	J:74593
	abnormal neutrophil physiology	J:74593, J:77597
	abnormal vascular endothelial cell physiology	J:97513
	granulomatous inflammation	J:74593
	liver abscess	J:74593
	skin lesions	J:74593
Ncf1tm1Hbd/Ncf1tm1Hbd involves: C57BL/6	normal immune system phenotype	J:118561
Ncf1tm1Shl/Ncf1tm1Shl B6.129S2-Ncf1tm1Shl	abnormal angiogenesis	J:142617
	abnormal cardiac muscle contractility	J:133916
	abnormal cardiovascular system physiology	J:111142
	abnormal heart morphology	J:133916
	abnormal inflammatory response	J:142617
	abnormal locomotor activation	J:111410
	abnormal postnatal growth	J:142617
	abnormal response to cardiac infarction	J:133916
	abnormal spatial learning	J:111410
	abnormal vascular smooth muscle physiology	J:111142
	abnormal vascular wound healing	J:142617
	cardiac hypertrophy	J:133916
	dilated heart left ventricle	J:133916
	enhanced long-term potentiation	J:111410
	granulomatous inflammation	J:111142
	impaired cued conditioning behavior	J:111410
	increased angiotensin I-converting enzyme activity	J:111142
	increased circulating renin level	J:111142
	increased systemic arterial blood pressure	J:111142
	reduced long-term potentiation	J:111410
Ncf1tm1Shl/Ncf1tm1Shl involves: 129S2/SvPas	abnormal intestinal goblet cell morphology	J:206181
Ncf1tm1Shl/Ncf1tm1Shl involves: 129S2/SvPas * C57BL/6J	abnormal response to infection	J:28267
	decreased vasoconstriction	J:120187
	increased acute inflammation	J:28267
	increased susceptibility to induced morbidity/mortality	J:28267
	increased susceptibility to infection	J:28267